Literature DB >> 35902478

Cerebellum and Neurorehabilitation in Emotion with a Focus on Neuromodulation.

Kim van Dun1, Mario Manto2,3, Raf Meesen4,5.   

Abstract

More and more research has focused on the role of the cerebellum in emotions and social cognition. Structural cerebellar and cerebello-cerebral connectivity abnormalities have been identified in several prevalent neuropsychiatric conditions, which have in some cases even been linked to the severity of the emotional disorder.Non-invasive brain stimulation (NIBS) techniques are currently used to modulate neuronal excitability and tune the connectivity within and between neuronal networks. Targeting the cerebellum with NIBS in order to improve emotions and social behavior in neuropsychiatric conditions seems to be a very interesting and innovative approach. Several studies have already explored the effect of cerebellar vermis stimulation in patients with schizophrenia with promising results. Other neuropsychiatric disorders such as bipolar disorder (BD), obsessive-compulsive disorder (OCD), major depressive disorder, or generalized anxiety disorder (GAD) have received less attention with respect to cerebellar stimulation, although the cerebellum has been implicated in these disorders. We will address NIBS and neuropsychiatric disorders in this chapter. Future research should focus on combining cerebellar NIBS with neuroimaging to unravel the specific role of the cerebellum in emotional disorders. Such studies will be very valuable in establishing causal relationships between the structural and functional abnormalities that can be observed in these disorders, and in the search for neurophysiological biomarkers for emotions. However, it is still unclear which stimulation parameters are optimal. Moreover, an important factor to consider when applying cerebellar NIBS in order to improve emotional or other functioning is cerebellar reserve. Although the cerebellum has a wide variety of plasticity mechanisms and its structural organization intrinsically incorporates a lot of redundancy, this redundancy can be depleted. A certain amount of cerebellar reserve should be preserved to successfully apply NIBS.Systematic studies are therefore needed to clarify the optimal stimulation parameters, and methods should be developed to quantify cerebellar reserve in order to estimate the possible added value of NIBS in the rehabilitation of emotions.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Cerebellum; Emotion disorders; Neurorehabilitation; Non-invasive brain stimulation (NIBS)

Mesh:

Year:  2022        PMID: 35902478     DOI: 10.1007/978-3-030-99550-8_18

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   3.650


  73 in total

1.  Cerebro-cerebellar white matter connectivity in bipolar disorder and associated polarity subphenotypes.

Authors:  Georgios D Argyropoulos; Foteini Christidi; Efstratios Karavasilis; Georgios Velonakis; Anastasia Antoniou; Peter Bede; Ioannis Seimenis; Nikolaos Kelekis; Athanasios Douzenis; Olympia Papakonstantinou; Efstathios Efstathopoulos; Panagiotis Ferentinos
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-07-22       Impact factor: 5.067

2.  Consensus Paper: Cerebellum and Emotion.

Authors:  M Adamaszek; F D'Agata; R Ferrucci; C Habas; S Keulen; K C Kirkby; M Leggio; P Mariën; M Molinari; E Moulton; L Orsi; F Van Overwalle; C Papadelis; A Priori; B Sacchetti; D J Schutter; C Styliadis; J Verhoeven
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

3.  Prefronto-cerebellar tDCS enhances neurocognition in euthymic bipolar patients. Findings from a placebo-controlled neuropsychological and psychophysiological investigation.

Authors:  Francesco Saverio Bersani; Amedeo Minichino; Laura Bernabei; Francesco Spagnoli; Alessandra Corrado; Lucilla Vergnani; Daniela Mannarelli; Caterina Pauletti; Francesco Fattapposta; Massimo Biondi; Roberto Delle Chiaie
Journal:  J Affect Disord       Date:  2016-12-06       Impact factor: 4.839

4.  Transcranial direct current stimulation in treatment-resistant obsessive-compulsive disorder: An open-label pilot study.

Authors:  Remy Bation; Emmanuel Poulet; Frederic Haesebaert; Mohamed Saoud; Jerome Brunelin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-10-09       Impact factor: 5.067

Review 5.  Comparison of guidelines for the treatment of unipolar depression: a focus on pharmacotherapy and neurostimulation.

Authors:  A J Bayes; G B Parker
Journal:  Acta Psychiatr Scand       Date:  2018-03-25       Impact factor: 6.392

6.  Global resting-state functional magnetic resonance imaging analysis identifies frontal cortex, striatal, and cerebellar dysconnectivity in obsessive-compulsive disorder.

Authors:  Alan Anticevic; Sien Hu; Sheng Zhang; Aleksandar Savic; Eileen Billingslea; Suzanne Wasylink; Grega Repovs; Michael W Cole; Sarah Bednarski; John H Krystal; Michael H Bloch; Chiang-Shan R Li; Christopher Pittenger
Journal:  Biol Psychiatry       Date:  2013-11-04       Impact factor: 13.382

Review 7.  Repetitive transcranial magnetic stimulation (rTMS) for obsessive-compulsive disorder (OCD): an exploratory meta-analysis of randomized and sham-controlled trials.

Authors:  Marcelo T Berlim; Nicholas H Neufeld; Frederique Van den Eynde
Journal:  J Psychiatr Res       Date:  2013-04-21       Impact factor: 4.791

Review 8.  "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?

Authors:  N C Andreasen; S Paradiso; D S O'Leary
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

9.  Transcranial direct current stimulation in patients with obsessive compulsive disorder: A randomized controlled trial.

Authors:  Rémy Bation; Marine Mondino; Florent Le Camus; Mohamed Saoud; Jerome Brunelin
Journal:  Eur Psychiatry       Date:  2019-09-13       Impact factor: 5.361

Review 10.  Psychiatric rehabilitation of emotional disorders.

Authors:  Sang-Bin Baek
Journal:  J Exerc Rehabil       Date:  2014-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.